EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Extracellular matrix remodelling in obesity and metabolic disorders

Vishal Musale, David H Wasserman, Li Kang

Life Metabolism · 01.08.2023 · 2 (4)

DOI: 10.1093/lifemeta/load021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Metabolism, online erschienen am 26.05.2023. Verfasst von Vishal Musale und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Systems Medicine, School of Medicine, University of Dundee, Dundee, Scotland DD1 9SY, UK. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 197 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity causes extracellular matrix (ECM) remodelling which can develop into serious pathology and fibrosis, having metabolic effects in insulin-sensitive tissues. The ECM components may be increased in response to overnutrition. This review will focus on specific obesity-associated molecular and pathophysiological mechanisms of ECM remodelling and the impact of specific interactions on tissue metabolism. In obesity, a complex network of signalling molecules such as cytokines and growth factors has been implicated in fibrosis. Increased ECM deposition contributes to the pathogenesis of insulin resistance at least in part through the activation of cell surface integrin receptors and CD44 signalling cascades. These cell surface receptors transmit signals to the cell adhesome which orchestrates an intracellular response that adapts to the extracellular environment. Matrix proteins, glycoproteins, and polysaccharides interact through ligand-specific cell surface receptors that interact with the cytosolic adhesion proteins to elicit specific actions. Cell adhesion proteins may have catalytic activity or serve as scaffolds. The vast number of cell surface receptors and the complexity of the cell adhesome have made study of their roles challenging in health and disease. Further complicating the role of ECM-cell receptor interactions is the variation between cell types. This review will focus on recent insights gained from studies of two highly conserved, ubiquitous axes and how they contribute to insulin resistance and metabolic dysfunction in obesity. These are the collagen-integrin receptor-IPP (ILK-PINCH-Parvin) axis and the hyaluronan-CD44 interaction. We speculate that targeting ECM components or their receptor-mediated cell signalling may provide novel insights into the treatment of obesity-associated cardiometabolic complications.

Schlagwörter

Stichwörter der Autor:innen

extracellular matrixfibrosisinsulin resistancemetabolismobesity

Autor:innen und Institutionen

  • Division of Systems Medicine, School of Medicine, University of Dundee, Dundee, Scotland DD1 9SY, UK.
  • Department of Molecular Physiology and Biophysics, Mouse Metabolic Phenotyping Center, Vanderbilt University, Nashville, TN 37235, USA.

Förderung

  • NIDDK NIH HHS
  • British Heart Foundation

Zitieren

APA

Musale, V., Wasserman, D. H., & Kang, L. (2023). Extracellular matrix remodelling in obesity and metabolic disorders. Life Metabolism, 2(4). https://doi.org/10.1093/lifemeta/load021

Vancouver

Musale V, Wasserman DH, Kang L. Extracellular matrix remodelling in obesity and metabolic disorders. Life Metabolism. 2023;2(4). doi:10.1093/lifemeta/load021

BibTeX
@article{Musale2023,
  author = {Musale, Vishal and Wasserman, David H and Kang, Li},
  title = {Extracellular matrix remodelling in obesity and metabolic disorders},
  journal = {Life Metabolism},
  year = {2023},
  volume = {2},
  number = {4},
  doi = {10.1093/lifemeta/load021}
}
Kostenlos starten →